Company press releases
| Tid | Selskap | Tittel | Sektor | Kategori |
|---|---|---|---|---|
| 25 May 2023 07:00 CEST |
BERGENBIO | BerGenBio Announces Abstracts Accepted for Presentation at 2023 ASCO | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 24 May 2023 20:12 CEST |
BERGENBIO | Mandatory notification of trade by related party to Primary Insiders | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 23 May 2023 07:00 CEST |
BERGENBIO | BGBIO - Ex. subscription rights today | 20103010 Biotechnology | Ex Date |
| 22 May 2023 18:01 CEST |
BERGENBIO | BerGenBio ASA: Annual general meeting held | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 20 May 2023 12:05 CEST |
BERGENBIO | BerGenBio ASA - Updated key information relating to the preferential rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 20 May 2023 12:00 CEST |
BERGENBIO | BERGENBIO ASA - Terms of the partially underwritten rights issue | 20103010 Biotechnology | Inside information |
| 09 May 2023 18:14 CEST |
BERGENBIO | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 May 2023 18:14 CEST |
BERGENBIO | BerGenBio to hold business update conference call | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Apr 2023 15:00 CEST |
BERGENBIO | BERGENBIO ASA: Notice of Annual General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Apr 2023 13:01 CEST |
BERGENBIO | BERGENBIO ASA: Board approval of 2022 Annual Financial Statement and Annual Report 2022 | 20103010 Biotechnology | Annual financial and audit Reports |
| 25 Apr 2023 17:56 CEST |
BERGENBIO | BerGenBio ASA - Key information relating to the preferential rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Apr 2023 17:49 CEST |
BERGENBIO | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Apr 2023 17:48 CEST |
BERGENBIO | BerGenBio ASA: Foreslår delvis garantert fortrinnsrettsemisjon | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 25 Apr 2023 17:48 CEST |
BERGENBIO | BerGenBio ASA: Proposed partially underwritten rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 18 Apr 2023 07:00 CEST |
BERGENBIO | BerGenBio Presents Data on STK11 Loss of Function and AXL Activation at AACR | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 29 Mar 2023 20:39 CEST |
BERGENBIO | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Mar 2023 08:00 CEST |
BERGENBIO | BerGenBio to Present at Upcoming Scientific Conferences | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Mar 2023 07:00 CET |
BERGENBIO | BerGenBio to Present at the Carnegie Nordic Healthcare Conference | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 Mar 2023 11:00 CET |
BERGENBIO | BerGenBio Announces First Patient Dosed in Phase 1b/2a Trial Evaluating Bemcentinib in 1st Line Non-Small Cell Lung Cancer with STK11 Mutations | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Feb 2023 07:00 CET |
BERGENBIO | BerGenBio Reports Fourth Quarter 2022 Financial Results and Provides Business Update | 20103010 Biotechnology | Inside information |
| 15 Feb 2023 17:00 CET |
BERGENBIO | BerGenBio Announces Positive Data From Phase 2 Trial of Bemcentinib in Combination with Pembrolizumab in 2L+ NSCLC Patients | 20103010 Biotechnology | Inside information |
| 02 Feb 2023 07:00 CET |
BERGENBIO | BerGenBio Announces the Establishment of Oncology Scientific Advisory Board | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 01 Feb 2023 07:00 CET |
BERGENBIO | BerGenBio ASA: Invitation to fourth quarter 2022 results webcast | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 21 Dec 2022 08:58 CET |
BERGENBIO | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 Dec 2022 07:00 CET |
BERGENBIO | BerGenBio to present at DNB's Nordic Healthcare Conference | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 21 Nov 2022 21:30 CET |
BERGENBIO | BerGenBio ASA: Grant of share options | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 15 Nov 2022 07:00 CET |
BERGENBIO | BerGenBio reports third quarter 2022 financial results and provides business update | 20103010 Biotechnology | Inside information |
| 08 Nov 2022 07:00 CET |
BERGENBIO | BerGenBio ASA: Invitation to third quarter 2022 results webcast | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Oct 2022 07:00 CEST |
BERGENBIO | BerGenBio ASA Secures NOK 100 million Shareholder Loan Facility from Meteva AS | 20103010 Biotechnology | Inside information |
| 11 Oct 2022 07:00 CEST |
BERGENBIO | BerGenBio Announces Initiation of Phase 1b/2a Trial Evaluating Bemcentinib in 1st line Non-Small Cell Lung Cancer Patients Harboring STK11 Mutations | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Sep 2022 15:02 CEST |
BERGENBIO | BERGENBIO ANNOUCES FIRST PATIENT RANDOMIZED IN BEMCENTINIB TRIAL IN EU-SOLIDACT PLATFORM FOR HOSPITALIZED COVID-19 PATIENTS | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 07 Sep 2022 07:00 CEST |
BERGENBIO | BerGenBio to Present at Pareto Securities' 13th Annual Healthcare Conference | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Aug 2022 07:00 CEST |
BERGENBIO | BerGenBio reports second quarter and half year 2022 financial results and provides business update | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 09 Aug 2022 07:00 CEST |
BERGENBIO | BERGENBIO ASA: Invitation to second quarter and half year 2022 results webcast | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Jun 2022 12:58 CEST |
BERGENBIO | BerGenBio - Mandatory notification of trade by Primary Insider | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 06 Jun 2022 18:18 CEST |
BERGENBIO | BERGENBIO PRESENTS CLINICAL DATA ON BEMCENTINIB IN COMBINATION WITH DOCETAXEL IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED NSCLC AT ASCO ANNUAL MEETING 2022 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 24 May 2022 07:00 CEST |
BERGENBIO | BERGENBIO ASA: RESULTS FOR THE FIRST QUARTER 2022 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 18 May 2022 07:00 CEST |
BERGENBIO | BERGENBIO ASA: INVITATION TO FIRST QUARTER 2022 RESULTS WEBCAST | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 May 2022 07:00 CEST |
BERGENBIO | BERGENBIO TO PRESENT AT ABG SUNDAL COLLIER LIFE SCIENCE SUMMIT | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 May 2022 07:00 CEST |
BERGENBIO | BERGENBIO ANNOUNCES LAUNCH OF BUSINESS STRATEGY FOCUSED ON NSCLC AND COVID-19 | 20103010 Biotechnology | Inside information |
| 28 Apr 2022 11:28 CEST |
BERGENBIO | BerGenBio ASA: Minutes from the Annual General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 26 Apr 2022 10:51 CEST |
BERGENBIO | BERGENBIO TO PRESENT AT ARCTIC SECURITIES BIOTECH WEBINAR | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 26 Apr 2022 07:00 CEST |
BERGENBIO | BERGENBIO ANNOUNCES COMPLETE DATA ANALYSIS OF ACCORD2 PHASE II BEMCENTINIB STUDY IN HOSPITALIZED COVID-19 PATIENTS - PRIMARY EFFICACY ENDPOINT MET | 20103010 Biotechnology | Inside information |
| 25 Apr 2022 07:00 CEST |
BERGENBIO | BERGENBIO PRESENTS BEMCENTINIB COVID-19 CLINICAL TRIAL DATA AT ECCMID 2022 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 Apr 2022 07:00 CEST |
BERGENBIO | BerGenBio strengthens its leadership team with appointment of Cristina Oliva as Chief Medical Officer | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 07 Apr 2022 15:00 CEST |
BERGENBIO | BERGENBIO ASA: NOTICE OF ANNUAL GENERAL MEETING | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 07 Apr 2022 14:01 CEST |
BERGENBIO | BERGENBIO ASA: BOARD APPROVAL OF 2021 ANNUAL FINANCIAL STATEMENT AND ANNUAL REPORT 2021 | 20103010 Biotechnology | Annual financial and audit Reports |
| 17 Mar 2022 08:15 CET |
BERGENBIO | BERGENBIO ANNOUNCES PUBLICATION IN CELL REPORTS MEDICINE JOURNAL INDICATING EFFICACY OF BEMCENTINIB IN STK11/LKB1 LUNG CANCER POPULATION | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Mar 2022 08:00 CET |
BERGENBIO | BERGENBIO TO PRESENT AT CARNEGIE VIRTUAL NORDIC HEALTHCARE SEMINAR | 20103010 Biotechnology | Non-regulatory press releases |
| 17 Mar 2022 07:00 CET |
BERGENBIO | BERGENBIO ANNOUNCES PUBLICATION IN CELL REPORTS MEDICINE JOURNAL INDICATING EFFICACY OF BEMCENTINIB IN STK11/LKB1 LUNG CANCER POPULATION | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |